Menu
Back to User profile » Dr Fu-Chao Liu
Papers published by Dr Fu-Chao Liu:
The MAP2K4/JNK/c-Jun Signaling Pathway Plays A Key Role In Dexmedetomidine Protection Against Acetaminophen-Induced Liver Toxicity
Chou AH, Liao CC, Lee HC, Liou JT, Liu FC
Drug Design, Development and Therapy 2019, 13:3887-3898
Published Date: 14 November 2019
Investigation of prostate resected weight on postoperative sexual dysfunction following transurethral resection of prostate surgery: a population-based study
Liu FC, Shen SJ, Lin JR, Yu HP
Therapeutics and Clinical Risk Management 2019, 15:113-118
Published Date: 10 January 2019
Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study
Tsai YF, Liu FC, Kuo CF, Chung TT, Yu HP
Therapeutics and Clinical Risk Management 2018, 14:1099-1110
Published Date: 12 June 2018
Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
Liu FC, Lin HT, Kuo C, MY Hsieh, See L, Yu HP
Clinical Epidemiology 2018, 10:631-641
Published Date: 30 May 2018
Familial aggregation of myasthenia gravis in affected families: a population-based study
Liu FC, Kuo CF, See LC, Tsai HI, Yu HP
Clinical Epidemiology 2017, 9:527-535
Published Date: 2 November 2017
Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation
Liu FC, Ting PC, Lin JR, Yu HP
Therapeutics and Clinical Risk Management 2017, 13:1391-1398
Published Date: 13 October 2017
Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
Liu FC, Lin HT, Lin JR, Yu HP
Therapeutics and Clinical Risk Management 2017, 13:1043-1051
Published Date: 18 August 2017